ResearcherThe University of Texas Southwestern Medical CenterNo recent work listed

Jack Hutcheson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6317-2788; OpenAlex author ID A5085023512. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2016: 1 paper

Papers 1

Immunologic and Metabolic Features of Pancreatic Ductal Adenocarcinoma Define Prognostic Subtypes of Disease. Co-author DOI 10.1158/1078-0432.ccr-15-1883 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Matthew R. Porembka · 1 shared paper, 2016 · strength 0.07
- Paper Immunologic and Metabolic Features of Pancreatic Ductal Adenocarcinoma Define Prognostic Subtypes of Disease. DOI 10.1158/1078-0432.ccr-15-1883 ↗
Megan Wachsmann · 1 shared paper, 2016 · strength 0.07
- Paper Immunologic and Metabolic Features of Pancreatic Ductal Adenocarcinoma Define Prognostic Subtypes of Disease. DOI 10.1158/1078-0432.ccr-15-1883 ↗
Erik S. Knudsen · 1 shared paper, 2016 · strength 0.07
- Paper Immunologic and Metabolic Features of Pancreatic Ductal Adenocarcinoma Define Prognostic Subtypes of Disease. DOI 10.1158/1078-0432.ccr-15-1883 ↗
Agnieszka Katarzyna Witkiewicz · 1 shared paper, 2016 · strength 0.07
- Paper Immunologic and Metabolic Features of Pancreatic Ductal Adenocarcinoma Define Prognostic Subtypes of Disease. DOI 10.1158/1078-0432.ccr-15-1883 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.